Michael Hiltensperger

9PUBLICATIONS
78CO-AUTHORS
Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsPredictive and prognostic markersAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 22, 2026
Proteomic and proteogenomic identification of targetable T-cell antigens in multiple myeloma.

|Dec 03, 2024
High-resolution profile of neoantigen-specific TCR activation links moderate stimulation to increased resilience of engineered TCR-T cells.

Franziska Füchsl, Johannes Untch, Vladyslav Kavaka

|Apr 30, 2024
Harnessing naturally occurring mutations for T-cell therapy: a potential new avenue to enhance treatment efficacy.

Michael Hiltensperger, Jürgen Ruland, Kilian Schober

|Mar 16, 2024
Author Correction: Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.

Celina Tretter, Niklas de Andrade Krätzig, Matteo Pecoraro

|Aug 02, 2023
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.

Celina Tretter, Niklas de Andrade Krätzig, Matteo Pecoraro

|Jun 08, 2021
Skin and gut imprinted helper T cell subsets exhibit distinct functional phenotypes in central nervous system autoimmunity.

Michael Hiltensperger, Eduardo Beltrán, Ravi Kant

Pageof 2

Frequent Collaborators

4 joint publications

Roland Rad

4 joint publications

Niklas de Andrade Krätzig

4 joint publications

Angela M Krackhardt

4 joint publications

Gabriela Zuleger